EKIMAS Corporation (ASNB) Stock
Currently, EKIMAS Corporation does not engage in significant business operations. In its earlier years, the company focused on creating specialized polymer materials used in the development of medical devices, designed to address various anatomical regions and health issues.
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Latest News
Cash Flow (USD)
Valuation & Return Ratios
Peer Comparison
About EKIMAS Corporation
Currently, EKIMAS Corporation does not engage in significant business operations. In its earlier years, the company focused on creating specialized polymer materials used in the development of medical devices, designed to address various anatomical regions and health issues. The firm's current objective is to identify, acquire, or combine with an existing operating entity through an equity-for-equity transaction. Established in 1993, this Las Vegas, Nevada-based entity was formerly known as AdvanSource Biomaterials Corporation, changing its name to EKIMAS Corporation in March 2020.
EKIMAS Corporation is headquartered in US.
EKIMAS Corporation (ASNB) stock trades at $0.85 with a market capitalization of $4.83M. The stock is valued at a price-to-earnings (P/E) ratio of -6.23, price-to-book of 0.25, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.55 and $1.70, and currently trades 50.0% below its 52-week high.
On profitability, EKIMAS Corporation generates a return on equity (ROE) of -7.06%, return on capital employed of -5.46%, an operating margin of 0.00%, a net profit margin of 0.00%.